Rupintrivir
Clinical data | |
---|---|
Trade names | Rupintrivir |
Legal status | |
Legal status |
|
Identifiers | |
| |
JSmol) | |
| |
|
Rupintrivir (AG-7088, Rupinavir) is a
3CL protease inhibitor.[1][2][3] It was developed for the treatment of rhinoviruses,[4][5] and has subsequently been investigated for the treatment of other viral diseases including those caused by picornaviruses,[6][7] norovirus,[8] and coronaviruses, such as SARS and COVID-19.[9][10]
See also
References